Cuts to cost of dwarfism drug to save families millions

Health Minister Mark Butler with Ari Abe-Apostolou, Oscar Rosein and Kiera Mckennon in Canberra. (Lukas Coch/AAP PHOTOS)

At only three months old, Oscar Rose was rushed to hospital for what ended up being emergency spinal therapy.

The now 10-year-old was born with achondroplasia, the most common form of dwarfism. 

His mother Hanna was forced to resuscitate him 20 times over the years due to breathing complications, but a new drug has helped cut out serious hospital visits.

Voxzogo will now be listed on the Pharmaceutical Benefits Scheme, reducing the cost of the drug from $330,000 a year to $30 a script, or just over $7 for concession card holders.

The treatment plan would usually last until the mid to late-teens, meaning millions of dollars would have otherwise been needed to continue on the drug.

More than 250 children worldwide are participating in trials for the drug's active ingredient, vosoritide, which is proving to be safe and effective.

Ms Rose said the treatment had helped the family remove aids around the house and given her son more independence. 

It's enabled him to grow at the same rate as a normal pre-teen.

"This is life-saving and life-changing," she said. 

It's also made life easier for Naoko Abe, who had to fly to Japan every fortnight to get treatment for her son Ari. 

While the cost of the trial was covered, the family spent thousands on flights. 

"The bank account balance has gone low, but you will do it," she said, welcoming the announcement alongside her son in Canberra on Wednesday.

The 12-year-old has grown four centimetres since December, meaning he can also access more things around the house, increasing his independence.

Professor Ravi Savarirayan said dwarfism was more than a condition affecting height, it also put pressure on spinal cords and led to other life-long complications. 

He said the drug was a game-changer and enabled those born with achondroplasia to live a normal life.

They are almost 50 times more likely to die before turning five than other children. 

"For many years, I was left in embarrassed silence when patients would ask me: 'What can you do about my child's problem?'," the specialist said, noting the gene had been found 30 years ago.

"We are trying to increase lifelong health for these children so that they can have increased independence, better functionality, decreased complications and hopefully put me out of a job."

Achondroplasia affects around one in 20,000 babies in Australia.  

Voxzogo has been approved in more than 37 countries. 

License this article

What is AAPNews?

For the first time, Australian Associated Press is delivering news straight to the consumer.

No ads. No spin. News straight-up.

Not only do you get to enjoy high-quality news delivered straight to your desktop or device, you do so in the knowledge you are supporting media diversity in Australia.

AAP Is Australia’s only independent newswire service, free from political and commercial influence, producing fact-based public interest journalism across a range of topics including politics, courts, sport, finance and entertainment.

What is AAPNews?
The Morning Wire

Wake up to AAPNews’ morning news bulletin delivered straight to your inbox or mobile device, bringing you up to speed with all that has happened overnight at home and abroad, as well as setting you up what the day has in store.

AAPNews Morning Wire
AAPNews Breaking News
Breaking News

Be the first to know when major breaking news happens.


Notifications will be sent to your device whenever a big story breaks, ensuring you are never in the dark when the talking points happen.

Focused Content

Enjoy the best of AAP’s specialised Topics in Focus. AAP has reporters dedicated to bringing you hard news and feature content across a range of specialised topics including Environment, Agriculture, Future Economies, Arts and Refugee Issues.

AAPNews Focussed Content
Subscription Plans

Choose the plan that best fits your needs. AAPNews offers two basic subscriptions, all billed monthly.

Once you sign up, you will have seven days to test out the service before being billed.

AAPNews Full Access Plan
Full Access
AU$10
  • Enjoy all that AAPNews has to offer
  • Access to breaking news notifications and bulletins
  • Includes access to all AAPNews’ specialised topics
Join Now
AAPNews Student Access Plan
Student Access
AU$5
  • Gain access via a verified student email account
  • Enjoy all the benefits of the ‘Full Access’ plan at a reduced rate
  • Subscription renews each month
Join Now
AAPNews Annual Access Plan
Annual Access
AU$99
  • All the benefits of the 'Full Access' subscription at a discounted rate
  • Subscription automatically renews after 12 months
Join Now

AAPNews also offers enterprise deals for businesses so you can provide an AAPNews account for your team, organisation or customers. Click here to contact AAP to sign-up your business today.

SEVEN DAYS FREE
Download the app
Download AAPNews on the App StoreDownload AAPNews on the Google Play Store